| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 163,789 | 217,381 | 193,895 | 261,322 | | Cost of Revenue | 58,223 | 54,916 | 58,809 | (47,088) | | | Gross Profit | 105,566 | 162,465 | 135,086 | 308,410 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (3,475) | 40,654 | 15,873 | 141,135 | | Non Recurring | 99,171 | 50,000 |
-
|
-
| | Others | 56,640 | 55,226 | 56,140 | 51,636 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (46,770) | 16,585 | 63,073 | 115,639 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 136,371 | (84,360) | 13,575 | (136,757) | | Earnings Before Interest And Taxes | 9,956 | 21,739 | 66,779 | 83,069 | | Interest Expense | 54,551 | 50,956 | 46,516 | 52,255 | | Income Before Tax | (44,595) | (29,217) | 20,263 | 30,814 | | Income Tax Expense | (1,148) | (682) | (1,653) | (17,065) | | Minority Interest | (3,537) | (6,152) |
-
| (495) | | | | Net Income From Continuing Ops | 49,227 | (139,473) | 41,427 | (62,611) | | | Non-recurring Events | | Discontinued Operations | 422 | (127) | 365 | 11,081 | | Extraordinary Items |
-
| 1,581 |
-
| 7 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 40,108 | (138,019) | 41,792 | (51,523) | | Preferred Stock And Other Adjustments | (11,822) | (8,454) | (15,190) | (11,822) | | | Net Income Applicable To Common Shares | $28,286 | ($146,473) | $26,602 | ($63,345) |
|
1.52% Nasdaq 0.00%
Income Statement
